COVID-19 AND NET FOREIGN EXCHANGE RESERVE RELATIONSHIP IN TURKEY: EVIDENCE FROM ARDL BOUNDS TESTING APPROACH

Abstract

Purpose- This work inquires whether there's a correlation between Covid-19 and the net foreign exchange reserve, which shows sensitivity to crises. Methodology- For this purpose, the daily data on COVID-19 seen in Turkey (case taken from Republic of Turkey Ministry of Health, cumulative case and infection rate data from Public Health Experts Association (HASUDER) and daily net foreign exchange reserve data calculated with the data obtained from the Central Bank of Turkey (CBT) balance sheet for the period between 11 March-14 May 2020 were tested applying the ARDL Bounds Test Approach and analyzed within the framework of the Error Correction Model (VECM). And to query short-run relationship, Granger Test over the VECM Model has been applied. Findings- According to the analysis result; There is a cointegration in the long-run between COVID-19 and the net foreign exchange reserve, and is statistically significant. Also, net foreign exchange reserve is a Granger cause for the quantity of cases, the cumulative quantity of cases, and the rate of infection in the short-run. Conclusion- In the process of transformation of a health crisis caused by a pandemic into a global economic crisis, this study contributes to the formation of the literature and is noteworthy with its results. Especially in the short-run, net foreign exchange reserves were determined to be a Granger cause of COVID-19, and therefore it was determined empirically that the change in reserves escalated the pandemic. The study is a contribution to the literature.

Keywords

• COVID-19,net foreign exchange reserve,bounds test,ARDL

References

1. Acemoğlu, D., Chernozhukov, V., Werning, I., and Whinston, M.D. (2020). Optimal Targeted Lockdowns in a Multi-Group SIR Model. NBER Working Paper No. 27102. DOI: 10.3386/w27102
2. Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., and Xia, L. (2020, Feb 20). Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. DOI:10.1148/radiol.2020200642
3. Alfaro, L., Chari, A., Greenland, A.N., and Schott, P.K. (2020). Aggregate and Firm-Level Stock Returns During Pandemics, in Real Time. NBER Working Paper No. 26950. DOI: 10.3386/w26950
4. Alhazzani, W. et al. (2020). Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med (2020), 46, 854–887. DOI:10.1007/s00134-020-06022-5
5. Alon, T.M., Doepke, M., Olmstead-Rumsey, J., and Tertilt, M. (2020). The Impact of COVID-19 on Gender Equality. NBER Working Paper No. 26947. DOI: 10.3386/w26947
6. Alstadsæter, A., Bratsberg, B., Eielsen, G., Kopczuk, W., Markussen, S., Raaum, O., and Røed, K. (2020). The First Weeks of the Coronavirus Crisis: Who Got Hit, When and Why? Evidence from Norway. NBER Working Paper No. 27131. DOI: 10.3386/w27131
7. Alvarez, F., Argente, D. and Lippi, F. (2020). A Simple Planning Problem for COVID-19 Lockdown. University of Chicago, Becker Friedman Institute for Economics Working Paper (2020-34).
8. Andrei, M. (2020, March 26). Iceland’s Testing Suggests 50% of COVID-19 Cases are Asymptomatic. 50ZME Science. Retrieved from https://www.zmescience.com/medicine/iceland-testing-covid-19-0523/

9. Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F.X., Chong, M., and Lee, M. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA, 323(16),1612-1614. DOI:10.1001/jama.2020.4326
10. Atkeson, A. (2020). How Deadly Is COVID-19? Understanding The Difficulties With Estimation Of Its Fatality Rate. NBER Working Paper 26965. DOI: 10.3386/w26965
11. Avery, C., Bossert, W., Clark, A., Ellison, G., and Ellison, S.F. (2020). Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists. NBER Working Paper 27007. DOI: 10.3386/w27007
12. Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D-Y., Chen, L., and Wang, M. (2020). Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA, 323(14), 1406–1407. DOI:10.1001/jama.2020.2565
13. Baker, S.R., Bloom, N., Davis, S.J., and Terry, S.J. (2020). Covid-Induced Economic Uncertainty. NBER Working Paper No.26983. DOI: 10.3386/w26983
14. Baker, S.R., Bloom, N., Davis, S.J., Kost, K.J., Sammon, M.C., and Viratyosin, T. (2020). The Unprecedented Stock Market Impact of COVID-19. NBER Working Paper 26945. DOI: 10.3386/w26945
15. Baker, S.R., Farrokhnia, R.A., Meyer, S., Pagel, M., and Yannelis, C. (2020, a). How Does Household Spending Respond to an Epidemic? Consumption During the 2020 COVID-19 Pandemic. NBER Working Paper No. 26949. DOI: 10.3386/w26949
16. Baker, S.R., Farrokhnia, R.A., Meyer, S., Pagel, M., and Yannelis, C. (2020, b). Income, Liquidity, and the Consumption Response to the 2020 Economic Stimulus Payments. NBER Working Paper No. 27097. DOI:10.3386/w27097
17. Baldwin, R., and Weder di Mauro, B. (2020). Economics in the Time of COVID-19, VoxEU CEPR Press. Retrieved from https://voxeu.org/debates/economics-time-covid-19
18. Barrero, J.M., Bloom, N., and Davis, S.J. (2020). COVID-19 Is Also a Reallocation Shock. NBER Working Paper No. 27137. DOI: 10.3386/w27137
19. Bartik, A.W., Bertrand, M., Cullen, Z.B., Glaeser, E.L., Luca, M., and Stanton, C.T. (2020). How Are Small Businesses Adjusting to COVID-19? Early Evidence from a Survey. NBER Working Paper 26989. DOI: 10.3386/w26989
20. Bendavid, E., Mulaney, B. Sood, N., Shah, S., Ling, E., Bromley-Dulfano, R., Lai, C., Weissberg, Z., Saavedra, R., Tedrow, J. et al. (2020). COVID-19 Antibody Seroprevalence in Santa Clara County, California. MedRxiv.
21. Berger, D., Herkenhoff, K. and Mongey, S. (2020). An Seir Infectious Disease Model with Testing and Conditional Quarantine. Working Paper, Federal Reserve Bank of Minneapolis.
22. Bernanke, B. and Yellen, J. (2020, Mar 18). The Federal Reserve Must Reduce Long-Term Damage from Coronavirus. Retrieved from https://www.ft.com/content/01f267a2-686c-11ea-a3c9-1fe6fedcca75
23. Breusch, T.S., and Pagan, A.R. (1979). A Simple Test for Heteroscedasticity and Random Coeffcient Variation. Econometrica, 47, 1287–1294.
24. Brown, R. L., Durbin, J., and Evans, J. M. (1975). Techniques for Testing the Constancy of Regression Relationships Over Time (with discussion). Journal of the Royal Statistical Society B, 37, 149–92.
25. Caballero, R.J. and Şimşek, A. (2020). A Model of Asset Price Spirals and Aggregate Demand Amplification of a "Covid-19" Shock. NBER Working Paper No. 27044. DOI:10.3386/w27044
26. CDC. Principles of Epidemiology in Public Health Practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics. Retrieved from https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section11.html
27. Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., Liao, J., Yang, H., Hou, W., and Zhang, Y. (2020). Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: a Retrospective Review of Medical Records. The Lancet, 395(10226), 809-815. DOI:10.1016/S0140-6736(20)30360-3
28. Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D., Song, S., Zhang, D., Qian, Z., Li, T., Shen, Y., and Lu, H. (Mar 2020). A Pilot Study of Hydroxychloroquine in Treatment of Patients with Moderate COVID-19. J Zhejiang Univ (Med Sci), 49(2), 215-219. DOI: 10.3785/j.issn.1008-9292.2020.03.03
29. Chen, L., Xiong, J., Baı, L. and Shi, Y. (2020). Convalescent Plasma as a Potential Therapy for COVID-19. The Lancet Infectious Diseases, 20(4), 398-400. DOI:10.1016/S1473-3099(20)30141-9
30. Chinazzi, M., Davis, J.T., Ajelli, M., Gioannini, C., Litvinova, M., Merler, S., Piontti, A.P., Mu, K., Rossi, L., Sun, K., Viboud, C., Xiong, X., Yu, H., Halloran, M.E., Longini Jr., I.M., and Vespignani, A. (2020). The Effect of Travel Restrictions on the Spread of the 2019 Novel Coronavirus (COVID-19) Outbreak. Science, 368 (6489), 395-400. DOI: 10.1126/science.aba9757
31. Coibion, O., Gorodnichenko, Y., and Weber, M. (2020, a). Labor Markets During the COVID-19 Crisis: A Preliminary View. NBER Working Paper No. 27017. DOI: 10.3386/w27017
32. Coibion, O., Gorodnichenko, Y., and Weber, M. (2020, b). The Cost of the Covid-19 Crisis: Lockdowns, Macroeconomic Expectations, and Consumer Spending. NBER Working Paper 27141. DOI:10.3386/w27141
33. Cucinotta, D. and Vanelli, M. (2020). WHO Declares COVID-19 a Pandemic. Acta Bio-medica: Atenei Parmensis, 91(1), 157-160. DOI: 10.23750/abm.v91i1.9397
34. Çiğdem, G. (2020). Multidisipliner Yaklaşımla İktisadi Kriz Olgusu. Ankara: Gazi Kitapevi.
35. Ding, W., Levine, R., Lin, C., and Xie, W. (2020). Corporate Immunity to the COVID-19 Pandemic. NBER Working Paper No. 27055. DOI: 10.3386/w27055
36. Dingel, J.I., and Neiman, B. (2020). How Many Jobs Can be Done at Home? NBER Working Paper No. 26948. DOI:10.3386/w26948
37. Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z. and Tong, S. (2020). Epidemiology of COVID-19 Among Children in China. Pediatrics, 145 (6) e20200702. DOI: https://doi.org/10.1542/peds.2020-0702
38. European Center for Disease Prevention and Control (ECDC). Communicable Disease Threats Report, 17-23 May 2020, Week 21. Retrieved from https://www.ecdc.europa.eu/sites/default/files/documents/Communicable-disease-threats-report-23-may-2020.pdf
39. Eichenbaum, M.S., Rebelo, S., and Trabandt, M. (2020). The Macroeconomics of Epidemics. NBER Working Paper No. 26882. DOI: 10.3386/w26882
40. Fahlenbrach, R., Rageth, K., and Stulz, R.M. (2020). How Valuable is Financial Flexibility when Revenue Stops? Evidence from the COVID-19 Crisis. NBER Working Paper No. 27106. DOI:10.3386/w27106
41. Faria e Castro, M. (2018). Fiscal Multipliers and Financial Crises. Working Papers 2018-23, Federal Reserve Bank of St. Louis. DOI: 10.20955/wp.2018.023
42. Fernández-Villaverde, J. and Jones, C.I. (2020). Estimating and Simulating a SIRD Model of COVID-19 for Many Countries, States, and Cities. NBER Working Paper 27128. DOI: 10.3386/w27128
43. Flaxman, S., Mishra, S., and Gandy, A.E.A. (2020, March 30). Estimating the Number of Infections and the Impact of Non-Pharmaceutical Interventions on Covid-19 in 11 European Countries. Imperial College London. DOI: /10.25561/77731
44. Fornaro, L., and Wolf, M. (2020). Covid-19 Coronavirus and Macroeconomic Policy. Retrieved from http://www.crei.cat/wp-content/uploads/2020/03/C19.pdf
45. Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., and Camporota, L. (2020). COVID-19 Pneumonia: Diferent Respiratory Treatments for Diferent Phenotypes? Intensive Care Med. DOI:10.1007/s00134-020-06033-2
46. Gautret, P., Lagier, J.-C., Parola, P., Hoang, V.T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V.E., Dupont, H.T., Honoré, S., Colson, P., Chabrière, E., Scola, B., Rolain, J.-M., Brouqui, P., Raoultac, D. (Mar 2020). Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Ttrial. International Journal of Antimicrobial Agents (2020). DOI:10.1016/j.ijantimicag.2020.105949
47. Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., and Lu, Z. (2020, Mar 27). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. DOI:10.1001/jamacardio.2020.1017
48. Girton, L., and Roper, D. (1977). A Monetary Model of Exchange Market Pressure Applied to the Postwar Canadian Experience. American Economic Review, 67(4), 537-548.
49. Godfrey, L.G. (1978). Testing for Multiplicative Heteroscedasticity. Journal of Econometrics, 8, 227–236.
50. Goldstein, J.R., and Lee, R.D. (2020). Demographic Perspectives on Mortality of Covid-19 and Other Epidemics. NBER Working Paper 27043. DOI:10.3386/w27043
51. Gregory, V., Menzio, G., and Wiczer, D.G. (2020). Pandemic Recession: L or V-Shaped? NBER Working Paper No. 27105. DOI:10.3386/w27105
52. Guerrieri, V., Lorenzoni, G., Straub, L., and Werning, I. (2020). Macroeconomic Implications of Covid-19: Can Negative Supply Schocks Cause Demand Shortages? NBER Working Paper No.26918. DOI: 10.3386/w26918
53. Halk Sağlığı Uzmanları Derneği (HASUDER). Kümülatif Vaka Sayısı ve Enfeksiyon Hızı. Retrieved from https://korona.hasuder.org.tr/hasuder-yeni-koronavirus-covid-19-haber-postasi-18-05-2020/
54. Harris, J.E. (2020). The Coronavirus Epidemic Curve is Already Flattening in New York City. NBER Working Paper 26917. DOI: 10.3386/w26917
55. Hassan, T.A., Hollander, S., Lent, L.V., and Tahoun, A. (2020). Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1. NBER Working Paper 26971. DOI: 10.3386/w26971
56. Hortaçsu, A., Liu, J., and Schwieg, T. (2020). Estimating the Fraction of Unreported Infections in Epidemics with a Known Epicenter: an Application to COVID-19. NBER Working Paper 27028. DOI: 10.3386/w27028
57. Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., Wang, J., Hu, Z., Yi, Y., and Shen, H. (2020). Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened Among Close Contacts in Nanjing, China. Sci China Life Sci, 63, 706–711. DOI:10.1007/s11427-020-1661-4
58. Jorda, O., Singh, S.S., and Taylor, A.M. (2020). Longer-Run Economic Consequences of Pandemics. NBER Working Paper No. 26934. DOI: 10.3386/w26934
59. Kahn, L.B., Lange, F., and Wiczer, D.G. (2020). NBER Working Paper No. 27061. DOI: 10.3386/w27061
60. Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., Arbous, M.S., Gommers, D.A.M.P.J., Kant, K.M., Kaptein, F.H.J., Paassen, J.v., Stals, M.A.M., Huisman, M.V., Endeman, H. (2020). Incidence of Thrombotic Complications in Critically ill ICU Patients with COVID-19. Thrombosis Research, 191, 145-147. DOI:10.1016/j.thromres.2020.04.013
61. Korolev, I. (2020, Apr 20). Identification and Estimation of the Seird Epidemic Model for COVID-19. SSRN Working paper. Retrieved from https://ssrn.com/abstract=3569367 or http://dx.doi.org/10.2139/ssrn.3569367
62. Krueger, D., Uhlig, H., and Xie, T. (2020). Macroeconomic Dynamics and Reallocation in an Epidemic. NBER Working Paper No. 27047. DOI:10.3386/w27047
63. Kuchler, T., Russel, D., and Stroebel, J. (2020). The Geographic Spread of COVID-19 Correlates with Structure of Social Networks as Measured by Facebook. NBER Working Paper 26990. DOI: 10.3386/w26990
64. Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., and Hsueh, P.-R. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19): The Epidemic and the Challenges. International Journal of Antimicrobial Agents, 55(3). DOI:10.1016/j.ijantimicag.2020.105924
65. Lauer, S.A., Grantz, K.H., Bi, Q., Jones, F.K., Zheng, Q., Meredith, H.R., Azman, A.S., Reich, N.G., and Lessler, J. (2020). The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. DOI:10.7326/M20-0504
66. Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W. and Shaman, J. (2020). Substantial Undocumented Infection Facilitates the Rapid Dissemination of Novel Coronavirus (Sarscov2). Science.
67. Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., and Zhao, Y. (2020). Prevalence and Impact of Cardiovascular Metabolic Diseases on COVID-19 in China. Clinical Research in Cardiology, 109, 531–538. DOI:10.1007/s00392-020-01626-9
68. Lin, P.Z., and Meissner, C.M. (2020). A Note on Long-Run Persistence of Public Health Outcomes in Pandemics. NBER Working Paper 27119. DOI:10.3386/w27119
69. Liu, Z., Magal, P., Seydi, O., and Webb, G. (2020a). Predicting the Cumulative Number of Cases for the Covid-19 Epidemic in China from Early Data. arXiv preprint arXiv:2002.12298 .
70. Liu, Z., Magal, P., Seydi, O., and Webb, G. (2020b). Understanding Unreported Cases in the Covid-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions. Biology, 9(3), 50.
71. Liu, Y., Yan, L.-M., Wan, L., Xiang, T.-X., Le, A., Liu, J.-M., Peiris, M., Poon, L.L., and Zhang, W. (2020). Viral Dynamics in Mild and Severe Cases of COVID-19. The Lancet Infectious Diseases. 20(6), 656-657. DOI:10.1016/S1473-3099(20)30232-2
72. Livingston, E. and Bucher, K. (2020). Coronavirus Disease 2019 (COVID-19) in Italy. JAMA, 323(14), 1335. DOI:10.1001/jama.2020.4344
73. Loayza, N.V., and Pennings, S. (2020). Macroeconomic Policy in the Time of COVID-19:A Primer for Developing Countries. Research and Policy Briefs No.28. World Bank, Washington, DC. © World Bank. https://openknowledge.worldbank.org/handle/10986/33540
74. Ludvigson, S.C., Ma, S., and Ng, S. (2020). Covid19 and the Macroeconomic Effects of Costly Disasters. NBER Working Paper No. 26987. DOI:10.3386/w26987
75. Manski, C.F., and Molinari, F. (2020). Estimating the COVID-19 Infection Rate: Anatomy of an Inference Problem. NBER Working Paper 27023. DOI: 10.3386/w27023
76. Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., and HLH Across Speciality Collaboration, UK (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, 395(10229), 1033–1034. DOI:10.1016/S0140-6736(20)30628-0
77. Mizumoto, K., Kagaya, K., Zarebski, A., and Chowell, G. (2020). Estimating the Asymptomatic Proportion of Coronavirus Disease 2019 (COVID-19) Cases on Board the Diamond Princess Cruise Ship, Yokohama, Japan, 2020 . Euro Surveill. 25(10): pii=2000180. DOI:10.2807/1560-7917.ES.2020.25.10.2000180
78. Mongey, S., Pilossoph, L. and Weinberg, A. (2020). Which Workers Bear the Burden of Social Distancing Policies? NBER Working Paper No. 27085. DOI: 10.3386/w27085
79. Montenovo, L., Jiang, X., Rojas, F.L., Schmutte, I.M., Simon, K.I., Weinberg,, B.A., and Wing, C. (2020). Determinants of Disparities in Covid-19 Job Losses. NBER Working Paper No. 27132. DOI: 10.3386/w27132
80. Musetti, A., Maluquer, C., Albasanz-Puig, A., Gudiol, C., Moreno-Gonzalez, G., Corradini, P. and Sureda, A. (2020). Handling the COVID-19 Pandemic in the Oncological Setting. The Lancet Haematology, 7(5), 365-366. DOI:10.1016/S2352-3026(20)30108-3
81. Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A.R., et al. (2020). Estimation of the Asymptomatic Ratio of Novel Coronavirus Infections (Covid-19). medRxiv.
82. Nishiura, H., Linton, N.M., and Akhmetzhanova, A.R. (2020). Serial Interval of Novel Coronavirus (COVID-19) Infections. International Journal of Infectious Diseases, 93, 284-286. DOI:10.1016/j.ijid.2020.02.060
83. Onder, G., Rezza, G., and Brusaferro, S. (2020). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 323(18), 1775-1776. DOI:10.1001/jama.2020.4683
84. Ozili, P.K., and Arun, T.G. (2020). Spillover of COVID-19: Impact on the Global Economy. SSRN Electronic Journal. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3562570
85. Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R.L., Yang, L., and Zheng, C. (2020). Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). DOI:10.1148/radiol.2020200370
86. Pesaran, M.H., Shin, Y., and Smith, R.J. (2001). Bounds Testing Approaches to the Analysis of Level Relationships. Journal of Applied Econometrics, 16(3), 289-326.
87. Peto, J. (2020). Covid-19 Mass Testing Facilities Could End the Epidemic Rapidly. BMJ 2020; 368. DOI:10.1136/bmj.m1163
88. Pindyck, R.S. (2020). COVID-19 and the Welfare Effects of Reducing Contagion. NBER Working Paper No. 27121. DOI: 10.3386/w27121
89. Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S. and Griffith, B. (2020). COVID-19–Associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. DOI:10.1148/radiol.2020201187
90. Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., and Tian, D.-S. (2020). Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, ciaa248. DOI:10.1093/cid/ciaa248
91. Remuzzi, A. and Remuzzi, G. (2020). COVID-19 and Italy: What Next? The Lancet, 395 (10231), 1225-1228. DOI:10.1016/S0140-6736(20)30627-9
92. Richardson, S., Hirsch, J.S., Narasimhan, M., et al. (2020). Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 2020, 323(20), 2052-2059. DOI:10.1001/jama.2020.6775
93. Rojas, F.L., Jiang, X., Montenovo, L., Simon, K.I., Weinberg, B.A., and Wing, C. (2020). Is the Cure Worse than the Problem Itself? Immediate Labor Market Effects of COVID-19 Case Rates and School Closures in the U.S. NBER Working Paper No. 27127. DOI:10.3386/w27127
94. Rothan, H.A. and Byrareddy, S.N. (2020). The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, DOI:10.1016/j.jaut.2020.102433
95. Ruan, Q., Yang, K., Wang, W., Jiang, L., and Song, J. (2020). Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China. Intensive Care Med, 46, 846–848. DOI:10.1007/s00134-020-05991-x
96. Sanders, J.M., Monogue, M.L., Jodlowski, T.Z., and Cutrell, J.B. (2020). Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA, 323(18), 1824-1836. DOI:10.1001/jama.2020.6019
97. Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., Wei, J., Xiao, H., Yang, Y., Qu, J., Qing, L., Chen, L., Xu, Z., Peng, L., Li, Y., Zheng, H., Chen, F., Huang, K., Jiang, Y., Liu, D., Zhang, Z., Liu, Y., and Liu, L. (2020). Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA, (16)323, 1582-1589. DOI:10,1001 / jama.2020.4783
98. Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J. Fan, Y., Zheng, C. (2020). Radiological Findings from 81 Patients with COVID-19 Pneumonia in Wuhan, China: a Descriptive Study. The Lancet Infectious Diseases, 20(4), 425-434. DOI:10.1016/S1473-3099(20)30086-4
99. Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., Huang, H., Yang, B., and Huang, C. (2020, Mar 25). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. DOI:10.1001/jamacardio.2020.0950
100. Singhal, T. (2020). A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics, 87, 281–286. Retrieved from https://link.springer.com/article/10.1007/s12098-020-03263-6
101. Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M. Kerwan, A., Al-Jabir, A., Losifidis, C., and Agha, R. (2020). World Health Organization Declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). International Journal of Surgery, 76, 71-76. DOI:10.1016/j.ijsu.2020.02.034
102. Stock, J. (2020). Data Gaps and the Policy Response to the Novel Coronavirus. NBER Working Paper No. 26902. DOI:10.3386/w26902
103. Surico, P., and Galeotti, A. (2020). The Economics of a Pandemic: The Case of Covid-19. Retrieved from https://icsb.org/wp-content/uploads/2020/03/LBS_Covid19_final.pdf.pdf.pdf.pdf-1.pdf.pdf
104. Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., Chen, H., Wang, D. Liu, N., Liu, D. Cheng, G. Zhang, Y., Li, D., Li, J., Lian, H., Niu, S., Zhang, L., Zhang, J. (2020). Characteristics of COVID-19 Infection in Beijing. Journal of Infection, 80(4), 401-406. DOI:10.1016/j.jinf.2020.02.018
105. T.C. Sağlık Bakanlığı, Retrieved from https://covid19.saglik.gov.tr/
106. Touret, F., and Lamballerie, X. (2020). Antiviral Research, 177, May 2020, 104762, DOI:10.1016/j.antiviral.2020.104762
107. Wang, H. and Zhang, L. (2020). Risk of COVID-19 for Patients with Cancer. The Lancet Oncology, 21(4), E181, 2020 DOI:10.1016/S1470-2045(20)30149-2
108. WHO, Retrieved from https://covid19.who.int/
109. WHO, HIV/AIDS, Global Health Observatory (GHO) Data, Retrieved from https://www.who.int/gho/hiv/en/
110. Worldometer, Distribution of Cases, Retrieved from https://www.worldometers.info/coronavirus/worldwide-graphs/#total-cases
111. Worldometer, Reported Cases and Deaths by Country, Territory, or Conveyance. Retrieved from https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?%22%20%5Cl%22countries
112. Wu, J. T., Leung, K., and Leung, G.M. (2020). Nowcasting and Forecasting the Potential Domestic and International Spread of the 2019-ncov Outbreak Originating in Wuhan, China: a Modelling Study. The Lancet, 395(10225), 689–697.
113. Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., Zhang, X., Pan, A., and Wei, H. (2020). Effective Treatment of Severe COVID-19 Patients with Tocilizumab. PNAS, 117 (20) 10970-10975. DOI:10.1073/pnas.2005615117
114. Zhao, S., Lin, Q., Ran, J., Musa, S.S., Yang, G., Wang, W., Lou, Y., Gao, D., Yang, L., He, D., et al. (2020). Preliminary Estimation of the Basic Reproduction Number of Novel Coronavirus (2019-ncov) in China, from 2019 to 2020: A Data-Driven Analysis in the Early Phase of the Outbreak. International Journal of Infectious Diseases, 92, 214–217.
115. Zhonghua Liu Xing Bing Xue Za Zhi (2020). Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention, 41(2), 145–151. DOI:10.3760/cma.j.issn.0254-6450.2020.02.003
116. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., and Cao, B. (2020). Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study. The Lancet, 395, 10229, 1054-1062. DOI:10.1016/S0140-6736(20)30566-3
117. Zu, Z.Y., Jiang, M.D., Xu, P.P., Chen, W., Ni, Q.Q., Lu, G.M., and Zhang, L.J. (2020). Coronavirus Disease 2019 (COVID-19): A Perspective from China. DOI:10.1148/radiol.2020200490